National Institute of Neurological Disorders and Stroke Amended; Notice of Meeting, 63414 [2014-25181]

Download as PDF 63414 Federal Register / Vol. 79, No. 205 / Thursday, October 23, 2014 / Notices mstockstill on DSK4VPTVN1PROD with NOTICES centers, special population programs, and other health systems; (2) provides assistance to communities, communitybased organizations, and BPHC programs related to the development, and expansion of primary care; (3) manages BPHC capital and loan guarantee programs; (4) leads and coordinates the analysis, development and drafting of budget and policy impacting BPHC programs; (5) provides support to the National Advisory Council on Migrant Health; (6) performs environmental scanning on issues that affect BPHC programs; (7) monitors BPHC activities in relation to HRSA and HHS Strategic Plan; and (8) consults and coordinates with other components within HRSA and HHS, and with other federal agencies, state and local governments, and other public and private organizations on issues affecting BPHC programs and policies. Office of Quality Improvement (RCK) The Office of Quality Improvement serves as the organizational focus for program performance including, clinical and operational quality improvement, patient safety and risk management, data reporting, and program evaluation. Specifically: (1) Provides leadership for implementing BPHC clinical quality and performance improvement strategies/ initiatives, including health information technology; (2) oversees BPHC Federal Tort Claims Act (FTCA) medical malpractice liability programs, reviewing, risk management and patient safety activities to improve policies and programs for primary health care services, including clinical information systems; (3) leads and coordinates BPHC national and state technical assistance/ programs and activities, including those focused on special populations; (4) identifies and provides assistance to BPHC programs around quality improvement and performance reporting activities; (5) oversees BPHC programs related to health information technology and quality improvement; (6) serves as BPHC focal point for the design and implementation of program evaluations; and (7) coordinates BPHC/ quality improvement and performance reporting activities within HRSA and HHS, and with other federal agencies, state and local governments, and other public and private organizations concerned with primary health care, eliminating health disparities, and improving the health status of the Nation’s underserved and vulnerable populations. Section RC–30, Delegations of Authority All delegations of authority and redelegations of authority made to HRSA VerDate Sep<11>2014 16:52 Oct 22, 2014 Jkt 235001 officials that were in effect immediately prior to this reorganization, and that are consistent with this reorganization, shall continue in effect pending further re-delegation. This reorganization is effective October 20, 2014. Dated: September 23, 2014. Mary K. Wakefield, Administrator. [FR Doc. 2014–25205 Filed 10–22–14; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke Amended; Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute of Neurological Disorders and Stroke Special Emphasis Panel, October 31, 2014, 12:00 p.m. to October 31, 2014, 3:00 p.m., National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 which was published in the Federal Register on October 15, 2014, 79FRN61884. The meeting date and time has been changed to November 11, 2014 from 11:00 a.m. to 4:00 p.m. The location remains the same. The meeting is closed to the public. Dated: October 17, 2014. Carolyn Baum, Program Analyst, Office of Federal Advisory Committee Policy. applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke; Special Emphasis Panel, NINDS T32 Training program. Date: December 1–2, 2014. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: One Washington Circle, One Washington Circle NW., Washington, DC 20037. Contact Person: Natalia Strunnikova, Ph.D., Scientific Review Officer, Scientific Review Branch, Division of Extramural Research, NINDS/NIH/DHHS/Neuroscience Center, 6001 Executive Boulevard, Suite 3208, MSC 9529, Bethesda, MD 20892–9529, 301–402–0288, natalia.strunnikova@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: October 17, 2014. Carolyn Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–25177 Filed 10–22–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meetings [FR Doc. 2014–25181 Filed 10–22–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel, Understanding SES Disparities in Cognitive Development. Date: November 18, 2014. Time: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\23OCN1.SGM 23OCN1

Agencies

[Federal Register Volume 79, Number 205 (Thursday, October 23, 2014)]
[Notices]
[Page 63414]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-25181]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke Amended; 
Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Institute of Neurological Disorders and Stroke Special Emphasis Panel, 
October 31, 2014, 12:00 p.m. to October 31, 2014, 3:00 p.m., National 
Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, 
Rockville, MD 20852 which was published in the Federal Register on 
October 15, 2014, 79FRN61884.
    The meeting date and time has been changed to November 11, 2014 
from 11:00 a.m. to 4:00 p.m. The location remains the same. The meeting 
is closed to the public.

    Dated: October 17, 2014.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-25181 Filed 10-22-14; 8:45 am]
BILLING CODE 4140-01-P